Total Payments
$467,637
2024 Payments
$26,851
Companies
55
Transactions
915
Medicare Patients
11,622
Medicare Billing
$1.0M
Payment Breakdown by Category
Royalty/License$178,000 (38.1%)
Other$172,143 (36.8%)
Consulting$75,590 (16.2%)
Food & Beverage$22,459 (4.8%)
Travel$17,440 (3.7%)
Research$1,689 (0.4%)
Education$316.77 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $178,000 | 10 | 38.1% |
| Consulting Fee | $75,590 | 13 | 16.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $75,165 | 22 | 16.1% |
| Current or prospective ownership or investment interest | $69,401 | 7 | 14.8% |
| Honoraria | $26,952 | 11 | 5.8% |
| Food and Beverage | $22,459 | 771 | 4.8% |
| Travel and Lodging | $17,440 | 59 | 3.7% |
| Unspecified | $1,689 | 16 | 0.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $625.00 | 1 | 0.1% |
| Education | $316.77 | 5 | 0.1% |
Payments by Type
General
$465,948
899 transactions
Research
$1,689
10 transactions
Ownership
$0
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medimetriks Pharmaceuticals, Inc. | $247,483 | 27 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $108,491 | 134 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $54,537 | 63 | $0 (2024) |
| Galderma Laboratories, L.P. | $24,079 | 83 | $0 (2024) |
| Promius Pharma LLC | $9,746 | 17 | $0 (2018) |
| EPI Health, LLC | $4,537 | 16 | $0 (2022) |
| UCB, Inc. | $3,491 | 19 | $0 (2024) |
| ABBVIE INC. | $2,209 | 92 | $0 (2024) |
| SANOFI US SERVICES INC. | $1,689 | 10 | $0 (2024) |
| Merz North America, Inc. | $1,212 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,851 | 126 | Galderma Laboratories, L.P. ($22,755) |
| 2023 | $27,644 | 132 | Sun Pharmaceutical Industries Inc. ($23,775) |
| 2022 | $63,106 | 138 | Sun Pharmaceutical Industries Inc. ($58,081) |
| 2021 | $19,233 | 112 | SUN PHARMACEUTICAL INDUSTRIES INC. ($17,325) |
| 2020 | $17,929 | 125 | Ortho Dermatologics, a division of Bausch Health US, LLC ($11,669) |
| 2019 | $11,712 | 105 | Sun Pharmaceutical Industries Inc. ($4,532) |
| 2018 | $116,527 | 153 | Medimetriks Pharmaceuticals, Inc. ($69,401) |
| 2017 | $184,636 | 24 | Medimetriks Pharmaceuticals, Inc. ($178,000) |
All Payment Transactions
915 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.46 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Medimetriks Pharmaceuticals, Inc. | Neo-Synalar (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Immunology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.25 | General |
| Category: Immunology | ||||||
| 12/05/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Inflammation & Immunology | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $34.20 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 11/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $1.08 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| 11/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $118.21 | General |
| 11/13/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: Dermatology | ||||||
| 11/11/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| 11/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: DERMATOLOGY | ||||||
| 10/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $121.86 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: DERMATOLOGY | ||||||
| 10/15/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| 10/15/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| 10/15/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Efficacy, Safety, PK, Biologics Monotherapy Study in Pts. with Moderate to Severe AD | SANOFI US SERVICES INC. | $1,689 | 10 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 3,045 | 4,931 | $1.2M | $264,500 |
| 2022 | 22 | 2,964 | 5,284 | $1.2M | $262,872 |
| 2021 | 26 | 2,870 | 5,114 | $1.1M | $253,762 |
| 2020 | 23 | 2,743 | 5,228 | $975,953 | $219,331 |
Total Patients
11,622
Total Services
20,557
Medicare Billing
$1.0M
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 739 | 964 | $368,773 | $83,469 | 22.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 140 | 212 | $108,183 | $26,785 | 24.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 281 | 322 | $99,029 | $23,240 | 23.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 439 | 565 | $114,433 | $22,355 | 19.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 229 | 256 | $88,071 | $21,808 | 24.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 164 | 164 | $81,595 | $17,769 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 220 | 257 | $69,730 | $16,686 | 23.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 306 | 1,479 | $29,986 | $7,572 | 25.3% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 21 | 21 | $25,296 | $6,475 | 25.6% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 16 | 16 | $20,618 | $5,337 | 25.9% |
| 10040 | Acne surgery | Office | 2023 | 18 | 61 | $21,465 | $5,283 | 24.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 123 | 138 | $23,366 | $5,048 | 21.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 31 | 35 | $18,865 | $4,543 | 24.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 48 | 48 | $16,073 | $3,607 | 22.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 61 | 73 | $11,090 | $2,947 | 26.6% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 23 | 29 | $11,645 | $2,877 | 24.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 19 | 20 | $7,628 | $1,910 | 25.0% |
| 17260 | Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less | Office | 2023 | 16 | 22 | $6,651 | $1,415 | 21.3% |
| 69100 | Biopsy of ear | Office | 2023 | 23 | 24 | $7,006 | $1,406 | 20.1% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 19 | $9,861 | $1,388 | 14.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 27 | 27 | $5,856 | $1,207 | 20.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 30 | 33 | $5,680 | $1,021 | 18.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 23 | $977.37 | $261.30 | 26.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 41 | 123 | $2,745 | $91.77 | 3.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 735 | 990 | $384,694 | $86,800 | 22.6% |
About Dr. Ronald Plott, M.D
Dr. Ronald Plott, M.D is a Dermatology healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1558569087.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Plott, M.D has received a total of $467,637 in payments from pharmaceutical and medical device companies, with $26,851 received in 2024. These payments were reported across 915 transactions from 55 companies. The most common payment nature is "Royalty or License" ($178,000).
As a Medicare-enrolled provider, Plott has provided services to 11,622 Medicare beneficiaries, totaling 20,557 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Fort Worth, TX
- Active Since 07/05/2007
- Last Updated 06/23/2011
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558569087
Products in Payments
- Loprox Cream (Drug) $178,000
- Winlevi (Drug) $89,600
- Loprox (Drug) $69,401
- SILIQ (Drug) $38,819
- DUOBRII (Drug) $11,304
- Odomzo (Drug) $9,201
- Trianex (Drug) $9,186
- ABSORICA (Drug) $4,493
- Sitavig (Drug) $3,933
- ODOMZO (Drug) $2,948
- ONEXTON (Drug) $2,541
- ABSORICA LD (Drug) $1,729
- DUPIXENT (Biological) $1,343
- RINVOQ (Biological) $898.06
- Exelderm (Drug) $834.90
- EUCRISA (Drug) $824.43
- JUBLIA (Drug) $784.62
- SKYRIZI (Biological) $562.80
- VTAMA (Drug) $546.57
- CLODERM (Drug) $538.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Fort Worth
Dr. Patrick Keehan, D.o, D.O
Dermatology — Payments: $761,024
Dermatology $761,024
William Cothern, Do, DO
Dermatology — Payments: $41,403
Dermatology $41,403
Stephen Weis, Do, DO
Dermatology — Payments: $32,162
Dermatology $32,162
Kathryn Durham, Md, MD
Dermatology — Payments: $28,437
Dermatology $28,437
Mrs. Betty Rajan, M.d, M.D
Dermatology — Payments: $25,857
Dermatology $25,857
Dr. James Mccarty, M.d, M.D
Dermatology — Payments: $20,110
Dermatology $20,110